ClinConnect ClinConnect Logo
Search / Trial NCT05862636

Who Fares Best With Mindfulness Meditation

Launched by PROF. DR. FILIP RAES · May 8, 2023

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring how mindfulness meditation affects people with different backgrounds and mental health issues, including healthy individuals and those dealing with depression. The goal is to find out who benefits the most from mindfulness practices and if there are any negative effects for some individuals. Researchers will look at factors like trauma symptoms, a tendency to disconnect from reality, and repetitive negative thinking to understand how these influence the effectiveness of mindfulness meditation on mental health.

To participate in the study, you need to be enrolled in a mindfulness-based intervention program at one of the participating sites. The study is open to all adults aged 65 and older. If you join, you will fill out questionnaires at different points during the program and a few months afterward to share your experiences regarding anxiety, depression, and overall well-being. Some participants will also have the chance to take part in interviews to discuss their thoughts in more detail. This trial is currently recruiting participants, so it’s an excellent opportunity to contribute to understanding how mindfulness can impact mental health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Enrolled in a mindfulness-based intervention at one of the participating sites
  • Exclusion Criteria:
  • Insufficient knowledge of the Dutch or English language (depending on the study site)
  • No internet access

About Prof. Dr. Filip Raes

Prof. Dr. Filip Raes is a distinguished clinical trial sponsor known for his expertise in translational medicine and metabolic research. With a robust academic background and a commitment to advancing healthcare, he leads innovative clinical trials aimed at enhancing patient outcomes through cutting-edge therapeutic approaches. His work emphasizes collaboration with interdisciplinary teams and a strong focus on evidence-based methodologies, ensuring that each trial is designed to meet the highest ethical and scientific standards. Prof. Raes is dedicated to fostering advancements in medical science, contributing to the development of novel treatments that address critical health challenges.

Locations

Antwerp, , Belgium

Deinze, , Belgium

Exeter, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Filip Raes, Prof. dr.

Principal Investigator

KU Leuven

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported